Regulatory News

Issue of Shares & Total Voting Rights

RNS Number : 6942D
Darktrace PLC
04 March 2022


04 March 2022

Darktrace plc


Issue and allotment of Shares in connection with the Acquisition of Cybersprint B.V. ("Cybersprint") and Total Voting Rights

On 23rd February 2022, Darktrace announced the acquisition of Cybersprint for €47.5 million ($53.7 million) to be paid approximately 75% in cash and 25% in equity. The completion of the acquisition occurred on 1 March 2022. In order to satisfy the 25% of the purchase prices due in equity, the Company has issued and allotted an aggregate of 2,573,648 new ordinary shares of 1 pence each in the Company (the "New Shares"). An application has been made for the New Shares to be admitted to the Premium Listing Segment of the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.

The New Shares will rank pari passu in all respects with Darktrace's existing ordinary shares of 1 pence each ("Ordinary Shares"). It is expected that admission will become effective on or around 7 March 2022.

As a result of 2,573,648 ordinary shares issued, the total number of ordinary shares outstanding is 701,785,353. Each Ordinary Share carries the right to one vote. Darktrace holds 2,341,783 Ordinary Shares as treasury shares with no voting rights. Therefore, the total voting rights figure of 699,443,570 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Darktrace under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.


Luk Janssens - Head of Investor Relations   [email protected]



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.